InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Discover the full record of transactions filed by Atlas Venture Fund X, L.P.. Director active across 3 companies, notably Kymera Therapeutics, Inc.. In total, 16 filings have been published. Total volume traded: €32.4m. The latest transaction was disclosed on 27 September 2021 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations16 total
€1m51,294 shares@ €21.971831.0% of flow
Common Stock
SEC:0001209191-21-058122·
€1m51,294 shares@ €21.971815.5% of flow
Common Stock
SEC:0001209191-21-058122:0·
€676,97630,560 shares@ €22.152318.6% of flow
Common Stock
SEC:0001209191-21-057719·
€676,97630,560 shares@ €22.15239.3% of flow
Common Stock
SEC:0001209191-21-057719:0·
01,000,000 shares0
Common Stock
SEC:0001209191-21-057041:0·
01,000,000 shares0
Common Stock
SEC:0001209191-21-057041·
€13m242,133 shares@ €51.95070.20% mcap100.0% of flow
Common Stock
SEC:0001209191-21-051015·
€13m242,133 shares@ €51.95070.20% mcap100.0% of flow
Common Stock
SEC:0001209191-21-051015:0·
€580,14426,858 shares@ €21.600416.0% of flow
Common Stock
SEC:0001209191-21-043499·
€580,14426,858 shares@ €21.60048.0% of flow
Common Stock
SEC:0001209191-21-043499:0·
€1m59,978 shares@ €20.835134.4% of flow
Common Stock
SEC:0001209191-21-042857·
€1m59,978 shares@ €20.835117.2% of flow
Common Stock
SEC:0001209191-21-042857:0·
01,000,000 shares0
Common Stock
SEC:0001209191-21-042076·
01,000,000 shares0
Common Stock
SEC:0001209191-21-042076:0·
01,122,619 shares0
Common Stock
SEC:0001209191-21-033694:0·
01,122,619 shares0
Common Stock
SEC:0001209191-21-033694·
16 of 16 declarations
About Atlas Venture Fund X, L.P.
Atlas Venture Fund X, L.P. is a director and insider at Kymera Therapeutics, Inc. and Generation Bio Co.
